Glucocorticoid receptor-induced non-muscle caldesmon regulates metastasis in castration-resistant prostate cancer

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
1 Online-Ressource.
Sprache
Englisch

Erschienen in
Glucocorticoid receptor-induced non-muscle caldesmon regulates metastasis in castration-resistant prostate cancer ; volume:12 ; number:1 ; day:12 ; month:8 ; year:2023 ; pages:1-12 ; date:12.2023
Oncogenesis ; 12, Heft 1 (12.8.2023), 1-12, 12.2023

Urheber
Virtanen, Verneri
Paunu, Kreetta
Kukkula, Antti
Niva, Saana
Junila, Ylva
Toriseva, Mervi
Jokilehto, Terhi
Mäkelä, Sari
Huhtaniemi, Riikka
Poutanen, Matti
Paatero, Ilkka
Sundvall, Maria
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1038/s41389-023-00485-z
URN
urn:nbn:de:101:1-2024020112311833194346
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:29 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Virtanen, Verneri
  • Paunu, Kreetta
  • Kukkula, Antti
  • Niva, Saana
  • Junila, Ylva
  • Toriseva, Mervi
  • Jokilehto, Terhi
  • Mäkelä, Sari
  • Huhtaniemi, Riikka
  • Poutanen, Matti
  • Paatero, Ilkka
  • Sundvall, Maria
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells

Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells

USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc

USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc

Targeting molecular resistance in castration-resistant prostate cancer

Targeting molecular resistance in castration-resistant prostate cancer

Evolving Personalized Therapy for Castration-Resistant Prostate Cancer

Evolving Personalized Therapy for Castration-Resistant Prostate Cancer

Osteoclasts directly influence castration-resistant prostate cancer cells

Osteoclasts directly influence castration-resistant prostate cancer cells

Effect of simvastatin on castration-resistant prostate cancer cells

Effect of simvastatin on castration-resistant prostate cancer cells

Ureter metastatic castration-resistant prostate cancer: a case report

Ureter metastatic castration-resistant prostate cancer: a case report

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends

Physician preferences for non-metastatic castration-resistant prostate cancer treatment

Physician preferences for non-metastatic castration-resistant prostate cancer treatment

Chromogranin A: a useful biomarker in castration-resistant prostate cancer

Chromogranin A: a useful biomarker in castration-resistant prostate cancer

Ailanthone: a new potential drug for castration-resistant prostate cancer

Ailanthone: a new potential drug for castration-resistant prostate cancer

Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches

Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches

Verbundene Objekte